These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29776840)

  • 1. [Breast cancer screening: CNGOF gets mobilized].
    Mathelin C; Nisand I
    Gynecol Obstet Fertil Senol; 2018 Jun; 46(6):507-508. PubMed ID: 29776840
    [No Abstract]   [Full Text] [Related]  

  • 2. [Breast cancer screening: The controversy continues… What's the interest for women?!].
    Barranger E; Delpech Y
    Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):325-326. PubMed ID: 28479072
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer screening: a dividing controversy.
    Khrouf S; Letaief Ksontini F; Ayadi M; Belhaj Ali Rais H; Mezlini A
    Tunis Med; 2020 Jan; 98(1):22-34. PubMed ID: 32395774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Too old for that? Only others believe it].
    Mathelin C; Nisand I
    Gynecol Obstet Fertil Senol; 2019; 47(7-8):547-548. PubMed ID: 31003020
    [No Abstract]   [Full Text] [Related]  

  • 5. [The French breast cancer screening program in 2022: Ensuring progress].
    Seradour B
    Bull Cancer; 2022; 109(7-8):756-759. PubMed ID: 35504758
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ultrasound for Breast Cancer Screening: an Effective Tool in a Personalized Screening].
    Meuwly JY
    Praxis (Bern 1994); 2015 Dec; 104(25):1399-404. PubMed ID: 26649958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for breast cancer: worries about its effectiveness].
    Autier P
    Rev Prat; 2013 Dec; 63(10):1369-77. PubMed ID: 24579331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What's new… in organized screening for breast cancer? - With profits subject to controversy and still insufficient coverage rate].
    Rollin I; Soyer P; Huchon C
    Gynecol Obstet Fertil; 2014 Apr; 42(4):252-3. PubMed ID: 24697928
    [No Abstract]   [Full Text] [Related]  

  • 9. [Breast cancer screening in thirteen French departments].
    Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Dialla PO; Pornet C; Poillot ML; Soler-Michel P; Sarlin N; Lunaud P; Desmidt P; Paré E; Mathis C; Rymzhanova R; Kuntz-Huon J; Exbrayat C; Bataillard A; Régnier V; Kalecinski J; Quantin C; Dumas A; Gentil J; Amiel P; Chauvin F; Dancourt V; Arveux P
    Bull Cancer; 2015 Feb; 102(2):126-38. PubMed ID: 25636359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based study of breast cancer screening in Côte d'Or (France): clinical implications and factors affecting screening round adequacy.
    Ouedraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P
    Eur J Cancer Prev; 2011 Nov; 20(6):462-74. PubMed ID: 22025137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systematic screening for breast cancer in Rhone].
    Courtial I; Brémond A; Victoria J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(1):9-16. PubMed ID: 8901296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast cancer screening program in France: for optimization of the information].
    Papin-Lefebvre F; Moutel G; Duchange N; de Montgolfier S; Sancho-Garnier H; Jullian O; Viguier J;
    Rev Epidemiol Sante Publique; 2014 Apr; 62(2):109-17. PubMed ID: 24630531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast cancer screening: On our way to the future].
    Delaloge S; Bachelot T; Bidard FC; Espie M; Brain E; Bonnefoi H; Gligorov J; Dalenc F; Hardy-Bessard AC; Azria D; Jacquin JP; Lemonnier J; Jacot W; Goncalves A; Coutant C; Ganem G; Petit T; Penault-Llorca F; Debled M; Campone M; Levy C; Coudert B; Lortholary A; Venat-Bouvet L; Grenier J; Bourgeois H; Asselain B; Arvis J; Castro M; Tardivon A; Cox DG; Arveux P; Balleyguier C; André F; Rouzier R;
    Bull Cancer; 2016 Sep; 103(9):753-63. PubMed ID: 27473920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
    Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
    Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys.
    Cutuli B; Dalenc F; Cottu PH; Gligorov J; Guastalla JP; Petit T; Amrate A
    Cancer Radiother; 2015 Aug; 19(5):295-302. PubMed ID: 26188735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raising awareness of organised breast cancer screening].
    Alba S; Horrillo S; Delemarle V; Pasti Yung V; Thiel C
    Rev Infirm; 2018 Oct; 67(244):42-43. PubMed ID: 30415690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is “mobile mammography” a Relevant Method in France?].
    Vallée A
    Sante Publique; 2016 Nov; 28(5):599-602. PubMed ID: 28155735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
    Séradour B; Allemand H; Weill A; Ricordeau P
    Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reluctances in organized breast cancer screenig in Yvelines].
    Tomietto M; Soyer P; Heitz D; Fauconnier A; Huchon C
    Gynecol Obstet Fertil; 2014 Nov; 42(11):761-5. PubMed ID: 25442823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer screening in women aged 50-74 years: is there room for improvement?
    Morère JF; Pivot X; Viguier J; Blay JY; Calazel-Benque A; Coscas Y; Roussel C; Eisinger F
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S8-S12. PubMed ID: 21245683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.